Search results
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 11% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Why BioNTech Was a Sickly Stock This Week
Motley Fool· 1 year agoWhat happened BioNTech (NASDAQ: BNTX), a company that rose to great prominence and a high stock price during the coronavirus pandemic, wasn't much of a...
Investors in BioNTech (NASDAQ:BNTX) have made a enviable return of 356% over the past three years
Simply Wall St. via Yahoo Finance· 1 year agoWhile BioNTech SE (NASDAQ:BNTX) shareholders are probably generally happy, the stock hasn't had...
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed the most recent trading day at $131.54, moving +0.59% from...
All You Need to Know About BioNTech SE Sponsored ADR (BNTX) Rating Upgrade to Buy
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) might move higher on growing optimism about its earnings prospects,...
BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion
Investor's Business Daily· 1 year agoBioNTech said Monday it expects roughly $5.4 billion in sales of its Covid vaccine this year, widely...
Why BioNTech Stock Was Sinking Today
Motley Fool· 9 months agoWhat happened A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech (NASDAQ: BNTX) stock on Monday. As of...
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
Motley Fool via Yahoo Finance· 5 months agoMany investors will likely be wearing big smiles as 2023 winds down. The S&P 500 is on track to...
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Investor's Business Daily· 7 months agoModerna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed...
